COASTLANDS CAPITAL LP enters ELOXX PHARMACEUTICALS, INC. with 1.25M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 5/2/2026ACC: 0001104659-26-054304
10% Owner
Since Apr 2026
1.25M
Baseline shares
0.00
Direct ownership
0 positions
29.36M
Derivative underlying
1 instrument
1
Security positions
1.25M indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned1.25M
Total
1.25M indirect1.25M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.25M | Indirect |
| Total | 1.25M | 1.25M indirect |
Derivative Holdings1
Pre-funded Warrant
IndirectUnderlying security
Common Stock
Underlying shares
29.36M
Shares owned
N/A
Exercise price
0.01
Expiration
—
Exercise window
—
Total
Underlying
29.36M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Pre-funded Warrant Indirect | Common Stock | 0.01 | — | — | 29.36M | N/A |
| Total | 29.36M | 0.00 | ||||